- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01146431
Memory During Inhalation Anesthesia Performed With or Without Bispectral Index (BIS) in Patients Undergoing Thyroidectomy
February 8, 2011 updated by: Catholic University of the Sacred Heart
The purpose of this study is 1) to investigate whether the use of BIS as a guide to the administration of inhaled anesthetic (sevoflurane or desflurane) compared with the use of hemodynamic parameters (blood pressure and heart rate) would affect the occurrence of implicit memory and /or dreams recall and 2) to check whether the occurrence of implicit memory and/or dreams recall is related with MAC (Minimal Alveolar Concentration) of inhalational anesthetics and/or preoperative anxiety levels.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
130
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rome, Italy, 00168
- Recruiting
- Catholic University Of Sacred Heart
-
Principal Investigator:
- Liliana Sollazzi, MD, Associate Professor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients undergoing general anesthesia for thyroidectomy
Description
Inclusion Criteria:
- Age between 18 and 70 years
- Class-ASA Physical Status I-II
Exclusion Criteria:
- Psychiatric or neurological disorders and/or hearing disorders
- Obesity (Body Mass Index > 30)
- Drug addiction, alcoholism
- Patient with difficulty in understanding italian language and/or education level below middle school
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Hemodynamic parameters
Hemodynamic parameters will be used as a guide for anesthesia.
|
Inhaled anaesthetic drugs (sevoflurane or desflurane) concentration will be changed on the basis of hemodynamic parameters (mean arterial pressure and heart rate greater or less than 20% compared to preoperative values).
Inhaled anaesthetic drugs (sevoflurane or desflurane) concentration will be changed on the basis of Bispectral Index (BIS) value which will be maintained between 40 and 50.
|
|
BIS
Bispectral Index (BIS) will be used as a guide for anesthesia.
|
Inhaled anaesthetic drugs (sevoflurane or desflurane) concentration will be changed on the basis of hemodynamic parameters (mean arterial pressure and heart rate greater or less than 20% compared to preoperative values).
Inhaled anaesthetic drugs (sevoflurane or desflurane) concentration will be changed on the basis of Bispectral Index (BIS) value which will be maintained between 40 and 50.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implicit memory
Time Frame: Approximately 24 hours after surgery
|
Implicit memory will be investigated using free association test: patients, during maintenance of anesthesia, will listen a piece of one of two stories, "Puss in Boots" or "Pinocchio", each followed by four keywords.
Approximately 24 hours after surgery, patients will be asked to associate the first thing that comes to mind with these keywords in order to highlight the presence of implicit memory.
The test will be repeated twice and will be positive if the patient will reply with the title of the story or a word of it.
|
Approximately 24 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dreams recall
Time Frame: Approximately 5 minutes after awakening from anesthesia
|
A first interview about dreams recall will be carried out 5 minutes after awakening from anesthesia.
Patients will be asked about dream content.
|
Approximately 5 minutes after awakening from anesthesia
|
|
Explicit memory
Time Frame: Approximately 24 hours after surgery
|
Patients will be asked about the last thing they remembered before going to sleep; the first thing they remember when they woke up; and anything which happen in between, including sounds, dreams and imagination.
|
Approximately 24 hours after surgery
|
|
Dreams recall
Time Frame: Approximately 24 hours after anaesthesia
|
Patients will be asked again about dreams recall.
The content of dreams will be analyzed using the 5-point Likert scales which contains the following dreams characteristics: memory content, emotional content, emotional intensity, vivid description, amount of sounds, meaning, how much movement, strange, episodic content, references to episodes of life.
|
Approximately 24 hours after anaesthesia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2010
Study Registration Dates
First Submitted
June 9, 2010
First Submitted That Met QC Criteria
June 16, 2010
First Posted (ESTIMATE)
June 17, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
February 9, 2011
Last Update Submitted That Met QC Criteria
February 8, 2011
Last Verified
January 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A/1051/2009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroidectomy
-
Oleksandr ButskiyInomedNot yet recruiting
-
Kyungpook National University Chilgok HospitalCompletedThyroidectomyKorea, Republic of
-
Aristotle University Of ThessalonikiCompleted
-
Keimyung University Dongsan Medical CenterUnknown
-
Yonsei UniversityCompletedThyroidectomyKorea, Republic of
-
Yonsei UniversityCompleted
-
China Medical University HospitalRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
NYU Langone HealthCompleted
Clinical Trials on Inhaled anesthetics
-
Alexza Pharmaceuticals, Inc.Completed
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; University of Pennsylvania; University... and other collaboratorsActive, not recruitingDepression | Quality of Life | Pain, Postoperative | Surgery | Anesthesia Morbidity | Surgery--Complications | Anesthesia | Nausea, Postoperative | Sleep Disorders, Circadian Rhythm | Anesthesia Awareness | Anesthesia Complication | Anesthesia Emergence DeliriumUnited States
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; University of MichiganRecruitingQuality of Life | Pain, Postoperative | Surgery | Anesthesia Morbidity | Anesthesia | Anesthesia Awareness | Anesthesia Complication | Surgery-ComplicationsUnited States
-
Stanford UniversityWithdrawnEndoscopy | ColonoscopyUnited States
-
Hamilton Health Sciences CorporationUnknownBronchiolitis ObliteransCanada
-
Synspira, Inc.TerminatedLung Diseases | Cystic Fibrosis | Pulmonary Disease | Antibiotic Resistant Infection | Respiratory Tract Disease | Cystic Fibrosis Pulmonary Exacerbation | Lung Inflammation | Burkholderia Infections | Lung Infection | Multi-antibiotic Resistance | Pulmonary Inflammation | Lung Infection Pseudomonal | Cystic Fibrosis... and other conditionsUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveCzechia, Hungary
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveHungary, Slovakia
-
Galecto Biotech ABCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Region SkaneCompletedIschemic Heart DiseaseSweden